Stay updated on Kadcyla Plus Pertuzumab vs. Herceptin Plus Pertuzumab Clinical Trial
Sign up to get notified when there's something new on the Kadcyla Plus Pertuzumab vs. Herceptin Plus Pertuzumab Clinical Trial page.

Latest updates to the Kadcyla Plus Pertuzumab vs. Herceptin Plus Pertuzumab Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check18 days agoChange DetectedThe page has been updated to include new drug information related to breast cancer treatments, specifically listing several drugs such as Paclitaxel, Epirubicin, and Doxorubicin, while significant details about a previous study on trastuzumab emtansine have been removed.SummaryDifference12%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check40 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check76 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.5%
- Check90 days agoChange DetectedThe web page has been updated to reflect a new version (v2.14.2) of the NLM-NCBI services and products, along with a notice about potential performance issues due to heavy traffic.SummaryDifference0.5%
Stay in the know with updates to Kadcyla Plus Pertuzumab vs. Herceptin Plus Pertuzumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Kadcyla Plus Pertuzumab vs. Herceptin Plus Pertuzumab Clinical Trial page.